These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12500971)

  • 1. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT.
    Betts R; Weinsheimer S; Blouse GE; Anagli J
    J Biol Chem; 2003 Mar; 278(10):7800-9. PubMed ID: 12500971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
    Betts R; Anagli J
    Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal conserved region in proteinase inhibitor domain of calpastatin potentiates its calpain inhibitory activity by interacting with calmodulin-like domain of the proteinase.
    Ma H; Yang HQ; Takano E; Hatanaka M; Maki M
    J Biol Chem; 1994 Sep; 269(39):24430-6. PubMed ID: 7929105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
    Jiao W; McDonald DQ; Coxon JM; Parker EJ
    Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
    Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
    Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
    Todd B; Moore D; Deivanayagam CC; Lin GD; Chattopadhyay D; Maki M; Wang KK; Narayana SV
    J Mol Biol; 2003 Apr; 328(1):131-46. PubMed ID: 12684003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting the active conformation of calpain with calpastatin-based reagents.
    Croall DE; Vanhooser LM; Cashon RE
    Biochim Biophys Acta; 2008 Nov; 1784(11):1676-86. PubMed ID: 18793761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
    Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W
    Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the active 27-residue fragment of human calpastatin.
    Ishima R; Tamura A; Akasaka K; Hamaguchi K; Makino K; Murachi T; Hatanaka M; Maki M
    FEBS Lett; 1991 Dec; 294(1-2):64-6. PubMed ID: 1743294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of the calpain-1/calpastatin complex promotes activation of calpain-1 under oxidizing conditions.
    Maddock Carlin KR; Steadham E; Huff-Lonergan E; Lonergan SM
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 38738874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli.
    Maki M; Takano E; Osawa T; Ooi T; Murachi T; Hatanaka M
    J Biol Chem; 1988 Jul; 263(21):10254-61. PubMed ID: 2839481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
    Kiss R; Kovács D; Tompa P; Perczel A
    Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene.
    Maki M; Bagci H; Hamaguchi K; Ueda M; Murachi T; Hatanaka M
    J Biol Chem; 1989 Nov; 264(32):18866-9. PubMed ID: 2553724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes.
    Kawasaki H; Emori Y; Suzuki K
    Arch Biochem Biophys; 1993 Sep; 305(2):467-72. PubMed ID: 8373185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calpain and calpastatin].
    Murachi T
    Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains.
    Ma H; Yang HQ; Takano E; Lee WJ; Hatanaka M; Maki M
    J Biochem; 1993 May; 113(5):591-9. PubMed ID: 8340353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic processing of human profilaggrin by active mu-calpain.
    Yamazaki M; Ishidoh K; Suga Y; Saido TC; Kawashima S; Suzuki K; Kominami E; Ogawa H
    Biochem Biophys Res Commun; 1997 Jun; 235(3):652-6. PubMed ID: 9207214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitric oxide and calpastatin on the inhibition of µ-calpain activity, autolysis and proteolysis of myofibrillar proteins.
    Liu R; Lonergan S; Steadham E; Zhou G; Zhang W; Huff-Lonergan E
    Food Chem; 2019 Mar; 275():77-84. PubMed ID: 30724261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
    Barnoy S; Glasner T; Kosower NS
    Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the active site of m-calpain and the interaction with calpastatin.
    Crawford C; Brown NR; Willis AC
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):135-42. PubMed ID: 8250833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.